Structural and biophysical characterization of the human mTOR kinase and its sig...
Structural and biophysical characterization of the human mTOR kinase and its signaling complexes
Cell growth and proliferation are fundamental processes whereby organisms accumulate mass and are therefore tightly regulated. Regulation is achieved by a complex network of signaling pathways responding to various environmental c...
ver más
¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video
Proyectos interesantes
NUTRITION
Cell growth control by nutrients
831K€
Cerrado
PROTEIN SYNTHESIS
The control of protein synthesis in health and disease
100K€
Cerrado
PID2020-114429RB-I00
BASES ESTRUCTURALES Y MOLECULARES DEL ENSAMBLAJE Y ACTIVACIO...
461K€
Cerrado
RariTOR
mTOR pathophysiology in rare human diseases
2M€
Cerrado
inhibiTOR
Exploiting Cellular Metabolism to Develop the Next Generatio...
150K€
Cerrado
MoTOR
Analysis of the moonlighting proteins in the mTOR signalli...
171K€
Cerrado
Información proyecto mTOR_complexes
Líder del proyecto
UNIVERSITAT BASEL
No se ha especificado una descripción o un objeto social para esta compañía.
TRL
4-5
Presupuesto del proyecto
185K€
Fecha límite de participación
Sin fecha límite de participación.
Descripción del proyecto
Cell growth and proliferation are fundamental processes whereby organisms accumulate mass and are therefore tightly regulated. Regulation is achieved by a complex network of signaling pathways responding to various environmental cues. A crucial nutrient and energy-sensitive pathway is centered on the Serine/Threonine kinase mechanistic target of rapamycin (mTOR). In the cell, mTOR interacts with several proteins to form two multi-subunit signaling complexes: mTORC1 and mTORC2. mTORC1 responds to the intracellular energy state reflected in amino acid and oxygen levels and integrates extracellular signals from growth factors to control cell size and proliferation. mTORC2 responds to growth factors and its downstream targets regulate cell survival and cytoskeletal organization. Consequently, deregulation of mTOR signaling is directly linked to human disorders like obesity, type II diabetes or cancer, which makes mTOR a highly relevant pharmaceutical target.
Although several aspects of mTOR signaling have been understood, the lack of intermediate to high-resolution structures impairs detailed understanding of complex assembly, function and regulation. We therefore propose to determine the structures of human mTOR complexes and their subunits by X-ray crystallography. The intended research involves initial medium-throughput expression screening of mTORC1/2 subunits in bacterial and insect cells followed by a biophysical characterization of the expressed proteins. Guided by the biophysical analysis, we will establish in vitro reconstitution protocols and identify promising candidate complexes for high-throughput crystallization screening, crystal optimization and structure determination. The structures should provide first insights into the organization of human mTOR (sub)complexes and their subunits. The proposed research will be of high general impact in academic and pharmaceutical research and will therefore significantly strengthen European scientific excellence.